Selective inhibition of Alu retrotransposition by APOBEC3G

Gene

Volumn 390, Issue 1-2, 2007, Pages 199-205

  Hulme, Amy E ^a   Bogerd, Hal P ^b   Cullen, Bryan R ^b   Moran, John V ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

APOBEC; LINE 1; Retrotransposon; Transposable element

Indexed keywords

ADENINE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE DEAMINASE; CYTOSINE; GUANINE; MESSENGER RNA; OPEN READING FRAME 1 PROTEIN; PROTEIN; RIBONUCLEOPROTEIN; TYROSINE; UNCLASSIFIED DRUG; VIF PROTEIN;

ARTICLE; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG INTERSPERSED REPEAT; OPEN READING FRAME; PRIORITY JOURNAL; PSEUDOGENE; RETROPOSON; VIRUS REPLICATION;

ALU ELEMENTS; BASE SEQUENCE; CYTOSINE DEAMINASE; DNA; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; NUCLEOSIDE DEAMINASES; PSEUDOGENES; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846895873     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2006.08.032     Document Type: Article

References (52)

1. Alisch R.S., Garcia-Perez J.L., Muotri A.R., Gage F.H., and Moran J.V. Unconventional translation of mammalian LINE-1 retrotransposons. Genes Dev. 20 (2006) 210-224
2. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.J., and Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14 (2004) 1392-1396
3. Bogerd H.P., Wiegand H.L., Doehle B.P., Lueders K.K., and Cullen B.R. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res. 34 (2006) 89-95
4. Bogerd H.P., et al. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 8780-8785
5. Britten R.J. Evidence that most human Alu sequences were inserted in a process that ceased about 307 million years ago. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 6148-6150
6. Brouha B., et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5280-5285
7. Callinan P.A., Wang J., Herke S.W., Garber R.K., Liang P., and Batzer M.A. Alu retrotransposition-mediated deletion. J. Mol. Biol. 348 (2005) 791-800
8. Chen H., et al. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol. 16 (2006) 480-485
9. Cullen B.R. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 80 (2006) 1067-1076
10. Dewannieux M., Esnault C., and Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat. Genet. 35 (2003) 41-48
11. Dombroski B.A., Mathias S.L., Nanthakumar E., Scott A.F., and Kazazian Jr. H.H. Isolation of an active human transposable element. Science 254 (1991) 1805-1808
12. Dombroski B.A., Scott A.F., and Kazazian Jr. H.H. Two additional potential retrotransposons isolated from a human L1 subfamily that contains an active retrotransposable element. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 6513-6517
13. Dutko J.A., Schafer A., Kenny A.E., Cullen B.R., and Curcio M.J. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr. Biol. 15 (2005) 661-666
14. Esnault C., Maestre J., and Heidmann T. Human LINE retrotransposons generate processed pseudogenes. Nat. Genet. 24 (2000) 363-367
15. Esnault C., et al. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433 (2005) 430-433
16. Esnault C., Millet J., Schwartz O., and Heidmann T. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Res 34 (2006) 1522-1531
17. Feng Q., Moran J.V., Kazazian Jr. H.H., and Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 87 (1996) 905-916
18. Gilbert N., Lutz-Prigge S., and Moran J.V. Genomic deletions created upon LINE-1 retrotransposition. Cell 110 (2002) 315-325
19. Gilbert N., Lutz S., Morrish T.A., and Moran J.V. Multiple fates of l1 retrotransposition intermediates in cultured human cells. Mol. Cell. Biol. 25 (2005) 7780-7795
20. Hache G., Liddament M.T., and Harris R.S. The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain. J. Biol. Chem. 280 (2005) 10920-10924
21. Han K., et al. Genomic rearrangements by LINE-1 insertion-mediated deletion in the human and chimpanzee lineages. Nucleic Acids Res. 33 (2005) 4040-4052
22. Harris R.S., et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113 (2003) 803-809
23. Hohjoh H., and Singer M.F. Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. EMBO J. 15 (1996) 630-639
24. Hohjoh H., and Singer M.F. Ribonuclease and high salt sensitivity of the ribonucleoprotein complex formed by the human LINE-1 retrotransposon. J. Mol. Biol. 271 (1997) 7-12
25. Holmes S.E., Singer M.F., and Swergold G.D. Studies on p40, the leucine zipper motif-containing protein encoded by the first open reading frame of an active human LINE-1 transposable element. J. Biol. Chem. 267 (1992) 19765-19768
26. Hulme A.E., Kulpa D.A., Garcia-Perez J.L., and Moran J.V. The impact of LINE-1 retrotransposition on the human genome. In: Lupski J., and Stankiewicz P. (Eds). Genomic Disorders: The Genomic Basis of Disease (2006), Humana Press, Totowa, NJ
27. Jarmuz A., et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79 (2002) 285-296
28. Kazazian Jr. H.H., Wong C., Youssoufian H., Scott A.F., Phillips D.G., and Antonarakis S.E. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332 (1988) 164-166
29. Kulpa D.A., and Moran J.V. Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum. Mol. Genet. 14 (2005) 3237-3248
30. Kulpa D.A., and Moran J.V. Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat. Struct. Mol. Biol. 13 (2006) 655-660
31. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
32. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., and Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424 (2003) 99-103
33. Mathias S.L., Scott A.F., Kazazian Jr. H.H., Boeke J.D., and Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 254 (1991) 1808-1810
34. Minakami R., Kurose K., Etoh K., Furuhata Y., Hattori M., and Sakaki Y. Identification of an internal cis-element essential for the human L1 transcription and a nuclear factor(s) binding to the element. Nucleic Acids Res. 20 (1992) 3139-3145
35. Moran J.V., Holmes S.E., Naas T.P., Deberardinis R.J., Boeke J.D., and Kazazian Jr. H.H. High frequency retrotransposition in cultured mammalian cells. Cell 87 (1996) 917-927
36. Muckenfuss H., et al. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem. (2006)
37. Navarro F., et al. Complementary function of the two catalytic domains of APOBEC3G. Virology 333 (2005) 374-386
38. Newman E.N., et al. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15 (2005) 166-170
39. Sassaman D.M., et al. Many human L1 elements are capable of retrotransposition. Nat. Genet. 16 (1997) 37-43
40. Sawyer S.L., Emerman M., and Malik H.S. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2 (2004) E275
41. Schumacher A.J., Nissley D.V., and Harris R.S. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9854-9859
42. Scott A.F., et al. Origin of the human L1 elements: proposed progenitor genes deduced from a consensus DNA sequence. Genomics 1 (1987) 113-125
43. Sheehy A.M., Gaddis N.C., Choi J.D., and Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 (2002) 646-650
44. Stenglein M.D., and Harris R.S. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J. Biol. Chem. 281 (2006) 16837-16841
45. Swergold G.D. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol. Cell. Biol. 10 (1990) 6718-6729
46. Symer D.E., et al. Human l1 retrotransposition is associated with genetic instability in vivo. Cell 110 (2002) 327-338
47. Turelli P., Vianin S., and Trono D. The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay. J. Biol. Chem. 279 (2004) 43371-43373
48. Wei W., Morrish T.A., Alisch R.S., and Moran J.V. A transient assay reveals that cultured human cells can accommodate multiple LINE-1 retrotransposition events. Anal. Biochem. 284 (2000) 435-438
49. Wei W., et al. Human L1 retrotransposition: cis preference versus trans complementation. Mol. Cell. Biol. 21 (2001) 1429-1438
50. Yu Q., Chen D., Konig R., Mariani R., Unutmaz D., and Landau N.R. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem. 279 (2004) 53379-53386
51. Zhang J., and Webb D.M. Rapid evolution of primate antiviral enzyme APOBEC3G. Hum. Mol. Genet. 13 (2004) 1785-1791
52. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., and Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424 (2003) 94-98